Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib

Overview of attention for article published in Drug Design, Development and Therapy, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 1 YouTube video.

Video abstract of review paper “Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with…